table of content
1 Introduction to Research & Analysis Reports
1.1 Tuberculosis Vaccine Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tuberculosis Vaccine Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tuberculosis Vaccine Drug Overall Market Size
2.1 Global Tuberculosis Vaccine Drug Market Size: 2023 VS 2030
2.2 Global Tuberculosis Vaccine Drug Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Tuberculosis Vaccine Drug Sales: 2019-2030
3 Company Landscape
3.1 Top Tuberculosis Vaccine Drug Players in Global Market
3.2 Top Global Tuberculosis Vaccine Drug Companies Ranked by Revenue
3.3 Global Tuberculosis Vaccine Drug Revenue by Companies
3.4 Global Tuberculosis Vaccine Drug Sales by Companies
3.5 Global Tuberculosis Vaccine Drug Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Tuberculosis Vaccine Drug Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Tuberculosis Vaccine Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tuberculosis Vaccine Drug Players in Global Market
3.8.1 List of Global Tier 1 Tuberculosis Vaccine Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Tuberculosis Vaccine Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Tuberculosis Vaccine Drug Market Size Markets, 2023 & 2030
4.1.2 Immune Vaccine
4.1.3 Therapy Vaccine
4.2 By Type - Global Tuberculosis Vaccine Drug Revenue & Forecasts
4.2.1 By Type - Global Tuberculosis Vaccine Drug Revenue, 2019-2024
4.2.2 By Type - Global Tuberculosis Vaccine Drug Revenue, 2025-2030
4.2.3 By Type - Global Tuberculosis Vaccine Drug Revenue Market Share, 2019-2030
4.3 By Type - Global Tuberculosis Vaccine Drug Sales & Forecasts
4.3.1 By Type - Global Tuberculosis Vaccine Drug Sales, 2019-2024
4.3.2 By Type - Global Tuberculosis Vaccine Drug Sales, 2025-2030
4.3.3 By Type - Global Tuberculosis Vaccine Drug Sales Market Share, 2019-2030
4.4 By Type - Global Tuberculosis Vaccine Drug Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tuberculosis Vaccine Drug Market Size, 2023 & 2030
5.1.2 Self-Procurement
5.1.3 UNICEF
5.1.4 Other
5.2 By Application - Global Tuberculosis Vaccine Drug Revenue & Forecasts
5.2.1 By Application - Global Tuberculosis Vaccine Drug Revenue, 2019-2024
5.2.2 By Application - Global Tuberculosis Vaccine Drug Revenue, 2025-2030
5.2.3 By Application - Global Tuberculosis Vaccine Drug Revenue Market Share, 2019-2030
5.3 By Application - Global Tuberculosis Vaccine Drug Sales & Forecasts
5.3.1 By Application - Global Tuberculosis Vaccine Drug Sales, 2019-2024
5.3.2 By Application - Global Tuberculosis Vaccine Drug Sales, 2025-2030
5.3.3 By Application - Global Tuberculosis Vaccine Drug Sales Market Share, 2019-2030
5.4 By Application - Global Tuberculosis Vaccine Drug Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Tuberculosis Vaccine Drug Market Size, 2023 & 2030
6.2 By Region - Global Tuberculosis Vaccine Drug Revenue & Forecasts
6.2.1 By Region - Global Tuberculosis Vaccine Drug Revenue, 2019-2024
6.2.2 By Region - Global Tuberculosis Vaccine Drug Revenue, 2025-2030
6.2.3 By Region - Global Tuberculosis Vaccine Drug Revenue Market Share, 2019-2030
6.3 By Region - Global Tuberculosis Vaccine Drug Sales & Forecasts
6.3.1 By Region - Global Tuberculosis Vaccine Drug Sales, 2019-2024
6.3.2 By Region - Global Tuberculosis Vaccine Drug Sales, 2025-2030
6.3.3 By Region - Global Tuberculosis Vaccine Drug Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Tuberculosis Vaccine Drug Revenue, 2019-2030
6.4.2 By Country - North America Tuberculosis Vaccine Drug Sales, 2019-2030
6.4.3 US Tuberculosis Vaccine Drug Market Size, 2019-2030
6.4.4 Canada Tuberculosis Vaccine Drug Market Size, 2019-2030
6.4.5 Mexico Tuberculosis Vaccine Drug Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Tuberculosis Vaccine Drug Revenue, 2019-2030
6.5.2 By Country - Europe Tuberculosis Vaccine Drug Sales, 2019-2030
6.5.3 Germany Tuberculosis Vaccine Drug Market Size, 2019-2030
6.5.4 France Tuberculosis Vaccine Drug Market Size, 2019-2030
6.5.5 U.K. Tuberculosis Vaccine Drug Market Size, 2019-2030
6.5.6 Italy Tuberculosis Vaccine Drug Market Size, 2019-2030
6.5.7 Russia Tuberculosis Vaccine Drug Market Size, 2019-2030
6.5.8 Nordic Countries Tuberculosis Vaccine Drug Market Size, 2019-2030
6.5.9 Benelux Tuberculosis Vaccine Drug Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Tuberculosis Vaccine Drug Revenue, 2019-2030
6.6.2 By Region - Asia Tuberculosis Vaccine Drug Sales, 2019-2030
6.6.3 China Tuberculosis Vaccine Drug Market Size, 2019-2030
6.6.4 Japan Tuberculosis Vaccine Drug Market Size, 2019-2030
6.6.5 South Korea Tuberculosis Vaccine Drug Market Size, 2019-2030
6.6.6 Southeast Asia Tuberculosis Vaccine Drug Market Size, 2019-2030
6.6.7 India Tuberculosis Vaccine Drug Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Tuberculosis Vaccine Drug Revenue, 2019-2030
6.7.2 By Country - South America Tuberculosis Vaccine Drug Sales, 2019-2030
6.7.3 Brazil Tuberculosis Vaccine Drug Market Size, 2019-2030
6.7.4 Argentina Tuberculosis Vaccine Drug Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Tuberculosis Vaccine Drug Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Tuberculosis Vaccine Drug Sales, 2019-2030
6.8.3 Turkey Tuberculosis Vaccine Drug Market Size, 2019-2030
6.8.4 Israel Tuberculosis Vaccine Drug Market Size, 2019-2030
6.8.5 Saudi Arabia Tuberculosis Vaccine Drug Market Size, 2019-2030
6.8.6 UAE Tuberculosis Vaccine Drug Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Tuberculosis Vaccine Drug Major Product Offerings
7.1.4 Merck Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.1.5 Merck Key News & Latest Developments
7.2 Japan BCG Lab
7.2.1 Japan BCG Lab Company Summary
7.2.2 Japan BCG Lab Business Overview
7.2.3 Japan BCG Lab Tuberculosis Vaccine Drug Major Product Offerings
7.2.4 Japan BCG Lab Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.2.5 Japan BCG Lab Key News & Latest Developments
7.3 Serum Institute of India
7.3.1 Serum Institute of India Company Summary
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India Tuberculosis Vaccine Drug Major Product Offerings
7.3.4 Serum Institute of India Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.3.5 Serum Institute of India Key News & Latest Developments
7.4 AJ Vaccines
7.4.1 AJ Vaccines Company Summary
7.4.2 AJ Vaccines Business Overview
7.4.3 AJ Vaccines Tuberculosis Vaccine Drug Major Product Offerings
7.4.4 AJ Vaccines Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.4.5 AJ Vaccines Key News & Latest Developments
7.5 BioFarma
7.5.1 BioFarma Company Summary
7.5.2 BioFarma Business Overview
7.5.3 BioFarma Tuberculosis Vaccine Drug Major Product Offerings
7.5.4 BioFarma Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.5.5 BioFarma Key News & Latest Developments
7.6 GreenSignal Bio Pharma
7.6.1 GreenSignal Bio Pharma Company Summary
7.6.2 GreenSignal Bio Pharma Business Overview
7.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Major Product Offerings
7.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.6.5 GreenSignal Bio Pharma Key News & Latest Developments
7.7 China National Biotec
7.7.1 China National Biotec Company Summary
7.7.2 China National Biotec Business Overview
7.7.3 China National Biotec Tuberculosis Vaccine Drug Major Product Offerings
7.7.4 China National Biotec Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.7.5 China National Biotec Key News & Latest Developments
7.8 Biomed Lublin
7.8.1 Biomed Lublin Company Summary
7.8.2 Biomed Lublin Business Overview
7.8.3 Biomed Lublin Tuberculosis Vaccine Drug Major Product Offerings
7.8.4 Biomed Lublin Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.8.5 Biomed Lublin Key News & Latest Developments
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Company Summary
7.9.2 Taj Pharmaceuticals Business Overview
7.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Drug Major Product Offerings
7.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.9.5 Taj Pharmaceuticals Key News & Latest Developments
7.10 Ataulpho de Paiva
7.10.1 Ataulpho de Paiva Company Summary
7.10.2 Ataulpho de Paiva Business Overview
7.10.3 Ataulpho de Paiva Tuberculosis Vaccine Drug Major Product Offerings
7.10.4 Ataulpho de Paiva Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.10.5 Ataulpho de Paiva Key News & Latest Developments
7.11 IVAC
7.11.1 IVAC Company Summary
7.11.2 IVAC Tuberculosis Vaccine Drug Business Overview
7.11.3 IVAC Tuberculosis Vaccine Drug Major Product Offerings
7.11.4 IVAC Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.11.5 IVAC Key News & Latest Developments
7.12 Queen Saovabha Mem. Inst
7.12.1 Queen Saovabha Mem. Inst Company Summary
7.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Business Overview
7.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Major Product Offerings
7.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.12.5 Queen Saovabha Mem. Inst Key News & Latest Developments
7.13 Microgen
7.13.1 Microgen Company Summary
7.13.2 Microgen Tuberculosis Vaccine Drug Business Overview
7.13.3 Microgen Tuberculosis Vaccine Drug Major Product Offerings
7.13.4 Microgen Tuberculosis Vaccine Drug Sales and Revenue in Global (2019-2024)
7.13.5 Microgen Key News & Latest Developments
8 Global Tuberculosis Vaccine Drug Production Capacity, Analysis
8.1 Global Tuberculosis Vaccine Drug Production Capacity, 2019-2030
8.2 Tuberculosis Vaccine Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Tuberculosis Vaccine Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tuberculosis Vaccine Drug Supply Chain Analysis
10.1 Tuberculosis Vaccine Drug Industry Value Chain
10.2 Tuberculosis Vaccine Drug Upstream Market
10.3 Tuberculosis Vaccine Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tuberculosis Vaccine Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
